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Résumé en
anglais
OBJECTIVE: The aspartate aminotransferase activity (AST)/alanine
aminotransferase activity (ALT) ratio is used as liver fibrosis index whereas the
reported data are conflicting. In chronic hepatitis C (CHC), reported diagnostic
accuracies range from none to good for significant fibrosis and to excellent for
cirrhosis. Assuming that AST/ALT increases are mainly due to vitamin B6 defects
since pyridoxal phosphate (PLP), active form of B6, acts as coenzyme in
transamination reactions, we evaluated the diagnostic accuracy of the AST/ALT
ratio using standardized methods for AST and ALT activities, with PLP addition as
recommended, in a prospective multicenter cohort of CHC patients.
METHODS: ALT and AST activities were measured using the recommended IFCC
methods with addition of pyridoxal 5'-phosphate. We evaluated the AST/ALT ratio
for the diagnosis of liver fibrosis or cirrhosis in a cohort of CHC patients included
in a multicenter prospective study. A liver biopsy was performed in each patient
and reviewed by two independent pathologists in order to determine the fibrosis
stage according to Metavir classification which was the reference standard.
RESULTS: AST/ALT ratio significantly increased with histological stage of liver
fibrosis and there was a significant correlation between Metavir fibrosis stage and
AST/ALT ratio (r=0.129, P<0.0035). The ROC curve analyses showed that the
AST/ALT ratio does not discriminate significant fibrosis (F≥2) (AUROC=0.531) and
had only very poor diagnostic accuracies for severe fibrosis (F≥3) (AUROC=0.584)
or cirrhosis (F4) (AUROC=0.626).
CONCLUSION: AST/ALT ratio is not a good and discriminative index of liver
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